UCLA’s Stein Eye Institute and The Doheny Eye Institute Offer Patients Access to Leading Vision Specialists

UCLA’s Stein Eye Institute and The Doheny Eye Institute Offer Patients Access to Leading Vision Specialists

medantaUCLA’s Stein Eye Institute and the Doheny Eye Institute have joined forces to offer patients easy access to leading vision specialists, providing top patient care. A total of 14 researchers and clinicians from the Doheny Eye Institute will join the ophthalmology faculty at the David Geffen School of Medicine at UCLA to provide leading research and education.

“The Stein–Doheny affiliation is a beautiful fit,” said Dr. Bartly Mondino, director of the Stein Eye Institute and chair of ophthalmology at the David Geffen School of Medicine at UCLA in a recent news release. “We share similar missions and have a long history of collaboration. This partnership expands UCLA’s footprint tremendously by providing patients with greater access to the top doctors in cornea, retina, glaucoma, neuroophthalmology and oculoplastics.”

Doheny Eye Institute clinics will unite with the UCLA Health network, with two Doheny Eye Center UCLA sites providing access to eye specialist care in new offices located in Arcadia and Fountain Valley. Doheny Eye Center UCLA’s main centre will be located in a new site in Pasadena.

“Since our establishment in 1947, the Doheny Eye Institute has worked to become the premier vision research and education eye institute in the world through the discovery of new knowledge, innovative eye-care therapies and the education of the leaders of ophthalmology and vision science,” said Ed Landry, chair of the Doheny Eye Institute board of directors in the news release. “UCLA and the Stein Eye Institute share our values and high standards for education, patient care and research. We expect that the combination of our two leading programs will result in even greater recognition and accomplishments.” The Institute treats a wide range of vision-related conditions, including glaucoma; macular degeneration; diseases of the cornea, retina and vitreous; cataracts and uveitis; intraocular inflammation; Graves’ disease; ptosis and lacrimal disease; and eyelid disease.

Even though the institutions will combine their research, clinical and training programs, the organizations will still maintain their identity. According to U.S. News and World Report’s 2015 “Best Hospitals,” Stein Eye and Doheny Eye Institutes are in 5th place of all the centers providing ophthalmology resources, demonstrating the quality of the organizations.

“We are honored to work with the Doheny Eye Institute to improve patient care throughout Southern California, while simultaneously extending the Stein Eye Institute’s research and educational outreach, which hold immense value for the nation and world,” said Dr. David Feinberg, president of the UCLA Health System, CEO of the UCLA Hospital System and associate vice chancellor of the Geffen School of Medicine in the news release “We appreciate this rare and unique opportunity to strengthen relationships with our distinguished colleagues at Doheny, many of whom have long collaborated with us in serving the Los Angeles community.”

Leave a Comment

Your email address will not be published.

Drag To Verify